Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model.

INTRODUCTION

Parkinson's disease (PD) is a representative neurodegenerative disease, and its diagnosis relies on the evaluation of clinical manifestations or brain neuroimaging in the absence of a crucial noninvasive biomarker. Here, we used non-targeted metabolomics profiling to identify metabolic alterations in the colon and plasma samples of ()-treated mice, which is a possible animal model for investigating the microbiota-gut-brain axis.

METHODS

We performed gas chromatography-mass spectrometry to analyze the samples and detected metabolites that could reflect -induced disease progression and pathology.

RESULTS AND DISCUSSION

Pattern, correlation and pathway enrichment analyses showed significant alterations in sugar metabolism such as galactose metabolism and fructose and mannose metabolism, which are closely associated with energy metabolism and lipid metabolism. This study indicates possible metabolic factors for -induced pathological progression and provides evidence of metabolic alterations associated with -mediated pathology of brain neurodegeneration.